The Weekly Roundup: December 18-22

Derm In The News: December 10-16

Keep up with the latest headlines in dermatology from the past week, including a new immuno-dermatology partnership, promising study results from a combined mRNA vaccine and Keytruda for advanced melanoma, and more.

Moderna and Merck’s V940 Plus Pembrolizumab Demonstrates Improvement in RFS and DMFS in Stage III/IV Melanoma After Complete Resection

At 3 years, V940 plus pembrolizumab reduced the risk of recurrence or death by 49% and the risk of distant metastasis or death by 62%.

South Korea Study Delves Into Safety Insights for JAK Inhibitors for Atopic Dermatitis

Pusan National University published the review in light of the growing body of JAK inhibitors in the AD space.

Case Study: Vitiligo Onset Following COVID-19 Vaccination

A recent study presents a unique case of sudden-onset vitiligo following the COVID-19 vaccination, along with a systematic review of existing literature to shed light on the potential link between vaccination and vitiligo development.

Atopic Dermatitis News to Use

Review a rundown of our top articles and resources for patients inspired by National Eczema Awareness Month.

POLL: Which Skin Cancer Drug Recently Received a Complete Response Letter From the FDA?

Click here to answer this week's poll about a recent FDA Complete Response Letter.

Immunotherapy in Melanoma: Navigating Special Patient Populations

The Society for Immunotherapy of Cancer recently published insights into the management of patients with preexisting autoimmune disease, solid organ transplant recipients, elderly individuals, those living with HIV, pregnant patients, and those with rare noncutaneous subtypes of melanoma.

Helping Patients Navigate New Environments to Manage Atopic Dermatitis

Roundtable participants shared 10 different considerations to make for a patient, like this 23-year-old woman, with a new environment and lifestyle.

ReV Up Your Vitiligo Treatment Strategies

Nanette Silverberg, MD, takes a deep dive into the importance of early intervention and gave an overview of topical care for patients of all ages with vitiligo.

FDA Approves Topical Gel Filsuvez for Epidermolysis Bullosa

Chiesi Global Rare Diseases recently announced the approval of the topical treatment.

Resiliency: A Fundamental Success Factor in Any Financial Plan

Check out these 5 factors that can significantly impact a dermatologist’s financial plan and should therefore incorporate flexibility and resiliency to structure the plan for long-term success.

Aesthetic Procedure Considerations for Skin of Color

Aesthetic Procedure Considerations for Skin of Color

Consider PDE4 Inhibitors for Mild to Moderate Psoriasis

Lisa Swanson, MD, FAAD, and Robert Casquejo, PA-C, discuss their preferred treatment approach for plaque psoriasis, which includes PDE4 inhibitors such as apremilast and roflumilast.

Reviewing New Tapinarof Data for Atopic Dermatitis Treatment

Tapinarof is showing promise in the landscape of dermatological treatment. Adelaide Hebert, MD, FAAD, recently served as an investigator for 2 studies presented at the European Academy of Dermatology and Venereology (EADV) Congress and discussed key points with Raj Chovatiya, MD, PhD.

Case Based Roundtables Part 1: Valorizing Topical Treatment Options for Patients With Vitiligo

Delve into challenging vitiligo cases and solutions discussed at recent Dermatology Times Case Based Roundtable events across the country.

Rashmi Sarkar, MD, FAMS: Vitiligo and Stigma

Sarkar spoke with Dermatology Times after the ReV conference to discuss her session on vitiligo stigma.

Can I Ask About Gun Ownership for My Safety?

Dr Derm has recently been sued by a patient for simply asking the question “Do you own a gun?” He seeks legal advice.

Frontline Forum Sneak Peek: Expert Insights on Psoriasis Treatment Guidelines

Read the top 10 takeaways from a recent discussion among experts in the management of plaque psoriasis.

More Images of Patients With Psoriasis Are Needed in Published Studies

Most studies involving the treatment of psoriasis do not contain any images of patients, a review finds.

Cellular Response Monitoring Provides Insight into Stable Vitiligo

Investigators evaluated vitiligo punch grafting effectiveness on stable vitiligo lesions.

Case Based Roundtables Part 2: Valorizing Topical Treatment Options for Patients With Vitiligo

Delve into challenging vitiligo cases and solutions discussed at recent Dermatology Times Case Based Roundtable events across the country.

Low Levels of Serum GLA in Rosacea Negatively Associated With Erythema, Anxiety, and Depression

Researchers observed lower levels of serum gamma linolenic acid in patients with rosacea.

Many Patients With Moderate to Severe AD Demonstrate Inadequate Disease Control with Systemic Therapies After 3 to 12 Months of Use

The study findings were presented in a poster at the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

Discovering Dermatology Times: December 2023

Learn more about the in-depth topics covered in the December 2023 print issue of Dermatology Times.

Study Examines Psychological Comorbidities Among Acne Patients Using Isotretinoin

The most prevalent psychological disorder among patients was anxiety.

Differences in Anti-PD-1/CTLA-4 and Anti-PD-1/LAG-3 Reported in Recent Study

The study examined the mechanisms of action associated with immune checkpoint inhibitor combination therapies.

Post Hoc Analyses Examine Real-World Efficacy and Safety of Tirbanibulin in Actinic Keratoses

The analyses were published in the Journal of the European Academy of Dermatology and Venereology.

Pointers With Portela: Topical Steroid Withdrawal

In this week’s Pointers With Portela, the 208SkinDoc reviews a patient case of topical steroid withdrawal.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.